| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CD8 receptor binding | 1.04e-07 | 9 | 109 | 4 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 1.04e-07 | 9 | 109 | 4 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.72e-07 | 10 | 109 | 4 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.72e-07 | 10 | 109 | 4 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.72e-07 | 10 | 109 | 4 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 4.02e-07 | 12 | 109 | 4 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.89e-06 | 17 | 109 | 4 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 3.81e-06 | 20 | 109 | 4 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.69e-05 | 32 | 109 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 5.11e-05 | 310 | 109 | 9 | GO:0030246 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 8.01e-05 | 42 | 109 | 4 | GO:0071889 | |
| GeneOntologyMolecularFunction | fructose-bisphosphate aldolase activity | 8.83e-05 | 3 | 109 | 2 | GO:0004332 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.47e-04 | 49 | 109 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | lyase activity | 1.64e-04 | 212 | 109 | 7 | GO:0016829 | |
| GeneOntologyMolecularFunction | NADPH:quinone reductase activity | 1.76e-04 | 4 | 109 | 2 | GO:0003960 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.84e-04 | 58 | 109 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 2.92e-04 | 5 | 109 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | aldehyde-lyase activity | 1.57e-03 | 11 | 109 | 2 | GO:0016832 | |
| GeneOntologyMolecularFunction | peptide binding | 1.81e-03 | 318 | 109 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.00e-03 | 239 | 109 | 6 | GO:0031406 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 4.72e-08 | 8 | 107 | 4 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.19e-06 | 16 | 107 | 4 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.55e-06 | 17 | 107 | 4 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.55e-06 | 17 | 107 | 4 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.98e-06 | 18 | 107 | 4 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.98e-06 | 18 | 107 | 4 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 5.62e-06 | 23 | 107 | 4 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 7.96e-06 | 25 | 107 | 4 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 7.96e-06 | 25 | 107 | 4 | GO:0002475 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 1.11e-05 | 9 | 107 | 3 | GO:0042270 | |
| GeneOntologyBiologicalProcess | positive regulation of RIG-I signaling pathway | 2.17e-05 | 11 | 107 | 3 | GO:1900246 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 2.20e-05 | 32 | 107 | 4 | GO:0019883 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.87e-05 | 169 | 107 | 7 | GO:0010977 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 2.93e-05 | 233 | 107 | 8 | GO:0031345 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 5.98e-05 | 41 | 107 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 6.58e-05 | 42 | 107 | 4 | GO:0001916 | |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 7.35e-05 | 196 | 107 | 7 | GO:0016052 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.12e-04 | 48 | 107 | 4 | GO:0002478 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.65e-04 | 53 | 107 | 4 | GO:0001914 | |
| GeneOntologyBiologicalProcess | regulation of RIG-I signaling pathway | 1.69e-04 | 21 | 107 | 3 | GO:0039535 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 2.34e-04 | 58 | 107 | 4 | GO:0019884 | |
| GeneOntologyBiologicalProcess | regulation of innate immune response | DHX58 HLA-A HLA-B HLA-G PUM2 ECSIT ZDHHC12 SLC15A2 MAPKAPK3 PUM1 | 3.70e-04 | 519 | 107 | 10 | GO:0045088 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting dopamine receptor signaling pathway | 3.95e-04 | 6 | 107 | 2 | GO:0007195 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DIP2B FLNA IFT140 AHI1 HLA-A HLA-B HLA-G HLA-H OBSL1 PUM2 HNF4A ADCY6 LIMK2 | 4.37e-04 | 846 | 107 | 13 | GO:0120035 |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 4.82e-04 | 70 | 107 | 4 | GO:0001913 | |
| GeneOntologyBiologicalProcess | RIG-I signaling pathway | 4.98e-04 | 30 | 107 | 3 | GO:0039529 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DIP2B FLNA IFT140 AHI1 HLA-A HLA-B HLA-G HLA-H OBSL1 PUM2 HNF4A ADCY6 LIMK2 | 5.27e-04 | 863 | 107 | 13 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 5.65e-04 | 129 | 107 | 5 | GO:0039531 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 5.96e-04 | 74 | 107 | 4 | GO:0002711 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.42e-08 | 7 | 109 | 4 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.43e-07 | 10 | 109 | 4 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 6.73e-07 | 14 | 109 | 4 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.58e-06 | 17 | 109 | 4 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 5.74e-06 | 23 | 109 | 4 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 9.57e-06 | 26 | 109 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.23e-05 | 35 | 109 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 4.96e-05 | 125 | 109 | 6 | GO:0140534 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 6.72e-05 | 42 | 109 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 7.39e-05 | 83 | 109 | 5 | GO:0030670 | |
| GeneOntologyCellularComponent | cis-Golgi network | 8.28e-05 | 85 | 109 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.14e-04 | 48 | 109 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 3.49e-04 | 64 | 109 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 5.56e-04 | 7 | 109 | 2 | GO:0072357 | |
| GeneOntologyCellularComponent | M band | 5.57e-04 | 31 | 109 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | nuclear envelope | 6.97e-04 | 560 | 109 | 10 | GO:0005635 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 8.62e-04 | 212 | 109 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 1.40e-03 | 157 | 109 | 5 | GO:0045335 | |
| GeneOntologyCellularComponent | secretory vesicle | SELP DNAJC13 CALCR ATR HLA-B GHDC HLA-H HP EHHADH AGL IRAG2 CCT8 SYTL1 ALDOA ALDOC | 2.03e-03 | 1246 | 109 | 15 | GO:0099503 |
| GeneOntologyCellularComponent | annulate lamellae | 2.35e-03 | 14 | 109 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | secretory granule | SELP DNAJC13 CALCR HLA-B GHDC HLA-H HP EHHADH AGL IRAG2 CCT8 ALDOA ALDOC | 2.38e-03 | 1014 | 109 | 13 | GO:0030141 |
| GeneOntologyCellularComponent | A band | 2.53e-03 | 52 | 109 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 2.64e-03 | 110 | 109 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.82e-03 | 112 | 109 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | tertiary granule lumen | 2.97e-03 | 55 | 109 | 3 | GO:1904724 | |
| GeneOntologyCellularComponent | azurophil granule membrane | 3.63e-03 | 59 | 109 | 3 | GO:0035577 | |
| GeneOntologyCellularComponent | endocytic vesicle | 4.01e-03 | 384 | 109 | 7 | GO:0030139 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 4.06e-03 | 124 | 109 | 4 | GO:1904813 | |
| MousePheno | spinal cord inflammation | 1.10e-07 | 8 | 90 | 4 | MP:0030987 | |
| MousePheno | abnormal myelination | 1.13e-05 | 166 | 90 | 8 | MP:0000920 | |
| MousePheno | demyelination | 1.75e-05 | 85 | 90 | 6 | MP:0000921 | |
| MousePheno | CNS inflammation | 2.44e-05 | 54 | 90 | 5 | MP:0006082 | |
| MousePheno | decreased immature NK cell number | 8.92e-05 | 14 | 90 | 3 | MP:0013666 | |
| Domain | Ig-like_fold | MPZ FLNA SDK2 HLA-A HLA-B UNC5B HLA-G HLA-H OBSL1 CAMTA2 ADAMTSL3 ITGB4 IGSF21 BTNL9 SEMA3E MYBPC3 | 2.58e-06 | 706 | 107 | 16 | IPR013783 |
| Domain | MHC_I_a_C | 3.61e-06 | 6 | 107 | 3 | IPR010579 | |
| Domain | MHC_I_C | 3.61e-06 | 6 | 107 | 3 | PF06623 | |
| Domain | IG_LIKE | MPZ SDK2 HLA-A HLA-B UNC5B HLA-G HLA-H OBSL1 ADAMTSL3 IGSF21 BTNL9 SEMA3E MYBPC3 | 4.66e-06 | 491 | 107 | 13 | PS50835 |
| Domain | MHC_I | 5.65e-06 | 21 | 107 | 4 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 5.65e-06 | 21 | 107 | 4 | IPR001039 | |
| Domain | Ig-like_dom | MPZ SDK2 HLA-A HLA-B UNC5B HLA-G HLA-H OBSL1 ADAMTSL3 IGSF21 BTNL9 SEMA3E MYBPC3 | 6.05e-06 | 503 | 107 | 13 | IPR007110 |
| Domain | ARM-like | 2.52e-05 | 270 | 107 | 9 | IPR011989 | |
| Domain | - | MPZ FLNA SDK2 HLA-A HLA-B UNC5B HLA-G OBSL1 ADAMTSL3 ITGB4 IGSF21 BTNL9 SEMA3E MYBPC3 | 2.54e-05 | 663 | 107 | 14 | 2.60.40.10 |
| Domain | Pumilio_RNA-bd | 3.25e-05 | 2 | 107 | 2 | IPR033712 | |
| Domain | - | 4.17e-05 | 222 | 107 | 8 | 1.25.10.10 | |
| Domain | PUF | 9.72e-05 | 3 | 107 | 2 | PF00806 | |
| Domain | FBA_I | 9.72e-05 | 3 | 107 | 2 | IPR000741 | |
| Domain | STPPase_N | 9.72e-05 | 3 | 107 | 2 | IPR031675 | |
| Domain | PUM_HD | 9.72e-05 | 3 | 107 | 2 | PS50303 | |
| Domain | PUM-HD | 9.72e-05 | 3 | 107 | 2 | IPR033133 | |
| Domain | STPPase_N | 9.72e-05 | 3 | 107 | 2 | PF16891 | |
| Domain | Glycolytic | 9.72e-05 | 3 | 107 | 2 | PF00274 | |
| Domain | Aldolase_I_AS | 9.72e-05 | 3 | 107 | 2 | IPR029768 | |
| Domain | ALDOLASE_CLASS_I | 9.72e-05 | 3 | 107 | 2 | PS00158 | |
| Domain | HEAT_type_2 | 1.17e-04 | 17 | 107 | 3 | IPR021133 | |
| Domain | ARM-type_fold | 1.45e-04 | 339 | 107 | 9 | IPR016024 | |
| Domain | PLAC | 1.66e-04 | 19 | 107 | 3 | PS50900 | |
| Domain | PLAC | 1.66e-04 | 19 | 107 | 3 | IPR010909 | |
| Domain | PUM | 1.94e-04 | 4 | 107 | 2 | PS50302 | |
| Domain | Pumilio_RNA-bd_rpt | 1.94e-04 | 4 | 107 | 2 | IPR001313 | |
| Domain | REJ | 1.94e-04 | 4 | 107 | 2 | PS51111 | |
| Domain | REJ_dom | 1.94e-04 | 4 | 107 | 2 | IPR014010 | |
| Domain | Pumilio | 1.94e-04 | 4 | 107 | 2 | SM00025 | |
| Domain | C1-set | 2.58e-04 | 54 | 107 | 4 | PF07654 | |
| Domain | IGc1 | 2.97e-04 | 56 | 107 | 4 | SM00407 | |
| Domain | Glyco_hydro_38_C | 3.22e-04 | 5 | 107 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 3.22e-04 | 5 | 107 | 2 | PF09261 | |
| Domain | Glyco_hydro_57/38_cen | 3.22e-04 | 5 | 107 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38 | 3.22e-04 | 5 | 107 | 2 | PF01074 | |
| Domain | - | 3.22e-04 | 5 | 107 | 2 | 1.20.1270.50 | |
| Domain | - | 3.22e-04 | 5 | 107 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 3.22e-04 | 5 | 107 | 2 | SM00872 | |
| Domain | Glyco_hydro_38_N | 3.22e-04 | 5 | 107 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 3.22e-04 | 5 | 107 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 3.22e-04 | 5 | 107 | 2 | IPR015341 | |
| Domain | Glyco_hydro_38C | 3.22e-04 | 5 | 107 | 2 | PF07748 | |
| Domain | - | 3.39e-04 | 24 | 107 | 3 | 3.30.500.10 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.39e-04 | 24 | 107 | 3 | IPR013273 | |
| Domain | MHC_I-like_Ag-recog | 3.39e-04 | 24 | 107 | 3 | IPR011161 | |
| Domain | Ig/MHC_CS | 3.41e-04 | 58 | 107 | 4 | IPR003006 | |
| Domain | Ig_C1-set | 3.41e-04 | 58 | 107 | 4 | IPR003597 | |
| Domain | IG_MHC | 3.88e-04 | 60 | 107 | 4 | PS00290 | |
| Domain | TSP_1 | 4.68e-04 | 63 | 107 | 4 | PF00090 | |
| Domain | Adcy_conserved_dom | 4.80e-04 | 6 | 107 | 2 | IPR009398 | |
| Domain | DUF1053 | 4.80e-04 | 6 | 107 | 2 | PF06327 | |
| Domain | PKD/REJ-like | 4.80e-04 | 6 | 107 | 2 | IPR002859 | |
| Domain | REJ | 4.80e-04 | 6 | 107 | 2 | PF02010 | |
| Domain | TSP1 | 5.27e-04 | 65 | 107 | 4 | SM00209 | |
| Domain | TSP1_rpt | 5.27e-04 | 65 | 107 | 4 | IPR000884 | |
| Domain | TSP1 | 5.27e-04 | 65 | 107 | 4 | PS50092 | |
| Domain | PKD | 6.70e-04 | 7 | 107 | 2 | PF00801 | |
| Domain | Quin_OxRdtase/zeta-crystal_CS | 6.70e-04 | 7 | 107 | 2 | IPR002364 | |
| Domain | QOR_ZETA_CRYSTAL | 6.70e-04 | 7 | 107 | 2 | PS01162 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 6.70e-04 | 7 | 107 | 2 | IPR011330 | |
| Domain | IG | 7.05e-04 | 421 | 107 | 9 | SM00409 | |
| Domain | Ig_sub | 7.05e-04 | 421 | 107 | 9 | IPR003599 | |
| Domain | AC_N | 8.90e-04 | 8 | 107 | 2 | IPR032628 | |
| Domain | Adcy | 8.90e-04 | 8 | 107 | 2 | IPR030672 | |
| Domain | AC_N | 8.90e-04 | 8 | 107 | 2 | PF16214 | |
| Domain | PKD/Chitinase_dom | 1.14e-03 | 9 | 107 | 2 | IPR022409 | |
| Domain | PKD | 1.14e-03 | 9 | 107 | 2 | SM00089 | |
| Domain | MHC_I/II-like_Ag-recog | 1.33e-03 | 38 | 107 | 3 | IPR011162 | |
| Domain | PKD | 1.73e-03 | 11 | 107 | 2 | PS50093 | |
| Domain | PKD_dom | 1.73e-03 | 11 | 107 | 2 | IPR000601 | |
| Domain | PKD_channel | 1.73e-03 | 11 | 107 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 1.73e-03 | 11 | 107 | 2 | IPR013122 | |
| Domain | - | 1.73e-03 | 11 | 107 | 2 | 2.60.40.670 | |
| Domain | PP2Ac | 2.43e-03 | 13 | 107 | 2 | SM00156 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 2.43e-03 | 13 | 107 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 2.43e-03 | 13 | 107 | 2 | PS00125 | |
| Domain | HEAT | 2.62e-03 | 48 | 107 | 3 | PF02985 | |
| Domain | PKS_ER | 3.70e-03 | 16 | 107 | 2 | IPR020843 | |
| Domain | ADH_N | 3.70e-03 | 16 | 107 | 2 | PF08240 | |
| Domain | PKS_ER | 3.70e-03 | 16 | 107 | 2 | SM00829 | |
| Domain | ADH_N | 3.70e-03 | 16 | 107 | 2 | IPR013154 | |
| Domain | Gal_mutarotase_SF_dom | 4.18e-03 | 17 | 107 | 2 | IPR011013 | |
| Domain | A/G_cyclase_CS | 4.18e-03 | 17 | 107 | 2 | IPR018297 | |
| Domain | HEAT | 4.49e-03 | 58 | 107 | 3 | IPR000357 | |
| Domain | LH2 | 4.69e-03 | 18 | 107 | 2 | SM00308 | |
| Domain | - | 4.69e-03 | 18 | 107 | 2 | 3.90.180.10 | |
| Domain | - | 4.69e-03 | 18 | 107 | 2 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 4.69e-03 | 18 | 107 | 2 | IPR029787 | |
| Domain | Ig_I-set | 4.76e-03 | 190 | 107 | 5 | IPR013098 | |
| Domain | I-set | 4.76e-03 | 190 | 107 | 5 | PF07679 | |
| Domain | ig | 4.76e-03 | 190 | 107 | 5 | PF00047 | |
| Domain | Immunoglobulin | 4.76e-03 | 190 | 107 | 5 | IPR013151 | |
| Domain | Guanylate_cyc | 5.22e-03 | 19 | 107 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.22e-03 | 19 | 107 | 2 | PS50125 | |
| Domain | A/G_cyclase | 5.22e-03 | 19 | 107 | 2 | IPR001054 | |
| Domain | 6-PGluconate_DH_C-like | 5.22e-03 | 19 | 107 | 2 | IPR008927 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.22e-03 | 19 | 107 | 2 | PS00452 | |
| Domain | ADH_zinc_N | 5.22e-03 | 19 | 107 | 2 | PF00107 | |
| Domain | ADH_SF_Zn-type | 5.22e-03 | 19 | 107 | 2 | IPR002085 | |
| Domain | CYCc | 5.22e-03 | 19 | 107 | 2 | SM00044 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.67e-07 | 9 | 87 | 4 | MM14527 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 3.88e-06 | 18 | 87 | 4 | MM14525 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.48e-06 | 6 | 87 | 3 | M47468 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 6.08e-06 | 20 | 87 | 4 | MM1374 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 7.81e-06 | 7 | 87 | 3 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 7.81e-06 | 7 | 87 | 3 | M47530 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 1.55e-05 | 25 | 87 | 4 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 1.55e-05 | 25 | 87 | 4 | MM1465 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 3.61e-05 | 11 | 87 | 3 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.80e-05 | 12 | 87 | 3 | M47529 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | DNAJC13 HLA-A HLA-B GHDC HLA-G HLA-H HP AGL CCT8 ALDOA ALDOC | 2.96e-04 | 511 | 87 | 11 | MM15330 |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.38e-04 | 54 | 87 | 4 | MM14871 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.63e-04 | 109 | 87 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.12e-04 | 111 | 87 | 5 | M27416 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 7.39e-04 | 29 | 87 | 3 | M1062 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.16e-04 | 68 | 87 | 4 | M27303 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 1705528 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 2808323 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 21088134 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 3.17e-09 | 7 | 109 | 4 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 3.17e-09 | 7 | 109 | 4 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 3.17e-09 | 7 | 109 | 4 | 2714856 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 3.17e-09 | 7 | 109 | 4 | 2391419 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 15671142 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 3.17e-09 | 7 | 109 | 4 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 3.17e-09 | 7 | 109 | 4 | 6242891 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 17512611 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 7018573 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 2642506 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 9037062 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 1840571 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 20957233 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 3.17e-09 | 7 | 109 | 4 | 11086076 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 12750360 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 3.17e-09 | 7 | 109 | 4 | 20974936 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 10704462 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 3.17e-09 | 7 | 109 | 4 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 3.17e-09 | 7 | 109 | 4 | 2584927 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 3496275 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 12147629 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 3458188 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 3.17e-09 | 7 | 109 | 4 | 1730883 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 3.17e-09 | 7 | 109 | 4 | 19004778 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 3.17e-09 | 7 | 109 | 4 | 6300850 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 3.17e-09 | 7 | 109 | 4 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 3.17e-09 | 7 | 109 | 4 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 3.17e-09 | 7 | 109 | 4 | 2906539 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 3013627 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 3.17e-09 | 7 | 109 | 4 | 3856254 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 3894562 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 27385590 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 3.17e-09 | 7 | 109 | 4 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 3.17e-09 | 7 | 109 | 4 | 18383043 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 16272298 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 3.17e-09 | 7 | 109 | 4 | 6956903 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 8833240 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 3.17e-09 | 7 | 109 | 4 | 6604582 | |
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 3.17e-09 | 7 | 109 | 4 | 6954478 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 34525366 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 3374494 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 3.17e-09 | 7 | 109 | 4 | 3025084 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 2543831 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 3.17e-09 | 7 | 109 | 4 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 3.17e-09 | 7 | 109 | 4 | 6786753 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 6583704 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 6571712 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 9222352 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 12006653 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 1699529 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 17982076 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 7520098 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 15644207 | ||
| Pubmed | How a single T cell receptor recognizes both self and foreign MHC. | 3.17e-09 | 7 | 109 | 4 | 17418792 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 9185075 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 21483793 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 10452993 | ||
| Pubmed | Intestinal epithelial cells modulate CD4 T cell responses via the thymus leukemia antigen. | 3.17e-09 | 7 | 109 | 4 | 21900182 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 15272181 | ||
| Pubmed | Genetic control of scrapie and Creutzfeldt-Jakob disease in mice. | 3.17e-09 | 7 | 109 | 4 | 6408182 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 26714929 | ||
| Pubmed | Partial nucleotide sequence of H-2Dd major histocompatibility antigen gene. | 3.17e-09 | 7 | 109 | 4 | 3925012 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 6280871 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 10799615 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 10993729 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 1339405 | ||
| Pubmed | H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. | 3.17e-09 | 7 | 109 | 4 | 10823851 | |
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 3.17e-09 | 7 | 109 | 4 | 19454713 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 10229092 | ||
| Pubmed | Comparison of nucleotide sequences of mRNAs belonging to the mouse H-2 multigene family. | 3.17e-09 | 7 | 109 | 4 | 6278432 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 7295646 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 2879284 | ||
| Pubmed | Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. | 3.17e-09 | 7 | 109 | 4 | 6952248 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 24064213 | ||
| Pubmed | Developmental Sculpting of Intracortical Circuits by MHC Class I H2-Db and H2-Kb. | 3.17e-09 | 7 | 109 | 4 | 25316337 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 7306483 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 2903482 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 28475642 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 2351932 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 17240452 | ||
| Pubmed | Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation. | 3.17e-09 | 7 | 109 | 4 | 1731192 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 1627536 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 32341060 | ||
| Pubmed | H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. | 3.17e-09 | 7 | 109 | 4 | 2422118 | |
| Interaction | LILRB1 interactions | 1.75e-05 | 10 | 108 | 3 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.75e-05 | 10 | 108 | 3 | int:LILRB2 | |
| Interaction | LOXL4 interactions | 2.04e-05 | 104 | 108 | 6 | int:LOXL4 | |
| Cytoband | 2p22-p21 | 1.55e-04 | 8 | 109 | 2 | 2p22-p21 | |
| Cytoband | 8q24.3 | 1.59e-04 | 113 | 109 | 4 | 8q24.3 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 2.22e-05 | 44 | 68 | 4 | 588 | |
| GeneFamily | Mannosidases alpha class 2 | 1.38e-04 | 5 | 68 | 2 | 1194 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.49e-04 | 161 | 68 | 5 | 593 | |
| GeneFamily | C1-set domain containing | 5.26e-04 | 42 | 68 | 3 | 591 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 6.15e-04 | 10 | 68 | 2 | 53 | |
| GeneFamily | Immunoglobulin like domain containing | 7.96e-04 | 193 | 68 | 5 | 594 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 1.06e-03 | 13 | 68 | 2 | 693 | |
| GeneFamily | Armadillo repeat containing|Importins | 2.05e-03 | 18 | 68 | 2 | 596 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.29e-03 | 19 | 68 | 2 | 50 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 2.53e-03 | 20 | 68 | 2 | 433 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 2.09e-08 | 21 | 108 | 5 | MM651 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 5.38e-08 | 25 | 108 | 5 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 4.78e-07 | 16 | 108 | 4 | MM3766 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 9.19e-07 | 43 | 108 | 5 | MM1204 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.01e-06 | 19 | 108 | 4 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 1.01e-06 | 19 | 108 | 4 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.26e-06 | 20 | 108 | 4 | MM3682 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 2.72e-06 | 24 | 108 | 4 | MM3773 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 4.54e-06 | 59 | 108 | 5 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 7.87e-06 | 31 | 108 | 4 | MM3729 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 7.91e-06 | 114 | 108 | 6 | MM3799 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 1.29e-05 | 35 | 108 | 4 | MM674 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 1.39e-05 | 74 | 108 | 5 | MM3796 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN | 1.67e-05 | 195 | 108 | 7 | M9813 | |
| Coexpression | GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 1.91e-05 | 199 | 108 | 7 | M9850 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 2.01e-05 | 39 | 108 | 4 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 2.01e-05 | 39 | 108 | 4 | MM3725 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 2.17e-05 | 203 | 108 | 7 | MM3795 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 2.45e-05 | 41 | 108 | 4 | MM710 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 3.06e-05 | 87 | 108 | 5 | MM652 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 3.26e-05 | 44 | 108 | 4 | MM3775 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 3.60e-05 | 90 | 108 | 5 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 3.89e-05 | 46 | 108 | 4 | MM3712 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 4.00e-05 | 92 | 108 | 5 | MM3748 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 5.01e-05 | 49 | 108 | 4 | MM1287 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 5.16e-05 | 97 | 108 | 5 | MM3789 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 5.42e-05 | 50 | 108 | 4 | MM3805 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | BICD2 FLNA MAN2C1 HLA-A HLA-B UNC5B HLA-G HLA-H MSR1 PKD1 OS9 | 5.94e-05 | 630 | 108 | 11 | MM1038 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 6.34e-05 | 52 | 108 | 4 | MM3808 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING | 7.20e-05 | 104 | 108 | 5 | MM3812 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 8.19e-05 | 541 | 108 | 10 | MM1061 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 8.49e-05 | 56 | 108 | 4 | MM3852 | |
| Coexpression | MOOTHA_GLYCOGEN_METABOLISM | 8.57e-05 | 21 | 108 | 3 | M10376 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 9.10e-05 | 57 | 108 | 4 | MM3716 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 1.04e-04 | 59 | 108 | 4 | MM3704 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 1.27e-04 | 187 | 108 | 6 | MM1034 | |
| Coexpression | DURAND_STROMA_NS_UP | 1.56e-04 | 194 | 108 | 6 | MM962 | |
| Coexpression | GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.65e-04 | 196 | 108 | 6 | M5349 | |
| Coexpression | GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.69e-04 | 197 | 108 | 6 | M5351 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN | 1.69e-04 | 197 | 108 | 6 | M9580 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 1.69e-04 | 197 | 108 | 6 | M7543 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 1.78e-04 | 126 | 108 | 5 | MM3711 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 1.79e-04 | 199 | 108 | 6 | M4571 | |
| Coexpression | GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP | 1.84e-04 | 200 | 108 | 6 | M388 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP | 1.84e-04 | 200 | 108 | 6 | M7437 | |
| Coexpression | MA_RAT_AGING_UP | 1.85e-04 | 127 | 108 | 5 | MM16096 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 2.38e-04 | 73 | 108 | 4 | M11428 | |
| Coexpression | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN | 2.50e-04 | 6 | 108 | 2 | M7182 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | CAD HLA-A SZT2 ANKRD50 TNRC18 HP IGSF21 TNPO3 FCHSD1 OPLAH MYBPC3 | 2.60e-04 | 746 | 108 | 11 | M40863 |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 2.63e-04 | 137 | 108 | 5 | MM16612 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 2.65e-04 | 75 | 108 | 4 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 2.65e-04 | 75 | 108 | 4 | MM3718 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 2.90e-04 | 140 | 108 | 5 | MM3705 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 3.10e-04 | 142 | 108 | 5 | MM3757 | |
| Coexpression | PEDRIOLI_MIR31_TARGETS_DN | 3.17e-04 | 413 | 108 | 8 | M2494 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN | 3.22e-04 | 222 | 108 | 6 | MM1132 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 3.63e-04 | 147 | 108 | 5 | MM3753 | |
| Coexpression | COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP | 3.71e-04 | 34 | 108 | 3 | M11581 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 3.72e-04 | 82 | 108 | 4 | MM3777 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 3.72e-04 | 82 | 108 | 4 | MM3858 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 4.08e-04 | 84 | 108 | 4 | MM1049 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 4.43e-04 | 330 | 108 | 7 | MM1120 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_T_CELL_AGEING | 4.45e-04 | 236 | 108 | 6 | MM3743 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 4.46e-04 | 86 | 108 | 4 | MM834 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 4.77e-04 | 156 | 108 | 5 | MM3763 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 4.87e-04 | 88 | 108 | 4 | MM1087 | |
| Coexpression | LEE_BMP2_TARGETS_UP | GALNT15 HLA-A HLA-B HLA-G HLA-H ITGB4 ADCY6 CRYZ SLC15A2 MAPKAPK3 OPLAH | 4.94e-04 | 805 | 108 | 11 | MM1067 |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 5.05e-04 | 158 | 108 | 5 | MM3851 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 5.30e-04 | 90 | 108 | 4 | MM3756 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 5.31e-04 | 244 | 108 | 6 | MM3706 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 5.53e-04 | 91 | 108 | 4 | MM3720 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_UROTHELIAL_CELL_AGEING | 5.98e-04 | 164 | 108 | 5 | MM3680 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 6.00e-04 | 93 | 108 | 4 | MM1185 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Radial_glial-RG|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.27e-07 | 200 | 109 | 7 | fb7c9c0e4beadad6e41e68f6f889e56650898d22 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.27e-07 | 200 | 109 | 7 | fff209256805a448393c385b79a70c2e2172e49c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 173 | 109 | 6 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-06 | 173 | 109 | 6 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 173 | 109 | 6 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 4.32e-06 | 173 | 109 | 6 | 1e8a43ff32eab95857c794e0bf4f0b0dba155b4a | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-06 | 173 | 109 | 6 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.47e-06 | 174 | 109 | 6 | e0de0a14319be1a115e5be05d6f9b562e7b32c4a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 182 | 109 | 6 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 182 | 109 | 6 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-06 | 183 | 109 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-06 | 184 | 109 | 6 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.96e-06 | 188 | 109 | 6 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | (10)_Ciliated-(0)_Reference|(10)_Ciliated / shred by cell type by condition | 8.33e-06 | 194 | 109 | 6 | f9d5bf6baddbd88947e6a740805962109649ed3b | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 8.83e-06 | 196 | 109 | 6 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 8.83e-06 | 196 | 109 | 6 | 5a0b5aeff7e535781ea2a4c85799bb468afcb6f8 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 9.09e-06 | 197 | 109 | 6 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | (04)_Interm._basal>secr.-(0)_Reference|(04)_Interm._basal>secr. / shred by cell type by condition | 9.09e-06 | 197 | 109 | 6 | 452462b372c66e7487de7b9140717954e1d05263 | |
| ToppCell | wk_20-22|World / Celltypes from embryonic and fetal-stage human lung | 9.36e-06 | 198 | 109 | 6 | 56eb765773a1a27a44262a447df7cfae8a9db90d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 109 | 6 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | 3a954d9d542e52c9b181f0850a09b1bff0a0c82d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | 7c66953ff6d8f16f4decd23c85232990d2d8c6c4 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 109 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | ASK440-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.26e-05 | 122 | 109 | 5 | 2f76ec3b527e9528fbb006599a96e8bbdf9e0e62 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.28e-05 | 138 | 109 | 5 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 142 | 109 | 5 | 0a87c0d74e281da5dc4f59e09a5e99c62b1ea801 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 148 | 109 | 5 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | Healthy-B_cell|Healthy / disease group, cell group and cell class | 3.74e-05 | 153 | 109 | 5 | 7f82cd61b3f1ebaee3e4bbf68ba858a67c2065e7 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_CTL|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.91e-05 | 162 | 109 | 5 | d53de64df2511eddba79f899fc3f48b1b059923f | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.91e-05 | 162 | 109 | 5 | ded08da888d8c481f0f96d1e0bfd03d617966910 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.91e-05 | 162 | 109 | 5 | 80619a93c57fe16daf91dc571874ef9ac888953d | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 164 | 109 | 5 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.01e-05 | 169 | 109 | 5 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 170 | 109 | 5 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 171 | 109 | 5 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.53e-05 | 172 | 109 | 5 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | Mild-CD4+_T_Exhausted|World / Disease group and Cell class | 6.53e-05 | 172 | 109 | 5 | efe68d9477aa873b1637ee689f298120303aa322 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-05 | 174 | 109 | 5 | 7ebf06076946729c1af25109df6066731097c3b1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 174 | 109 | 5 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-05 | 174 | 109 | 5 | 90961e8839514985712b8b986aec3391bb249ba7 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-05 | 174 | 109 | 5 | c4b0987d9394f977fe6bc6a4214a6d8d73d0abcc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-05 | 174 | 109 | 5 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.68e-05 | 178 | 109 | 5 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-05 | 179 | 109 | 5 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-05 | 179 | 109 | 5 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.30e-05 | 181 | 109 | 5 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 8.75e-05 | 183 | 109 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.75e-05 | 183 | 109 | 5 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.75e-05 | 183 | 109 | 5 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.44e-05 | 186 | 109 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 186 | 109 | 5 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.44e-05 | 186 | 109 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 189 | 109 | 5 | 0493f7b79127c207fd7ade778ef4810500495d7e | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7|World / Primary Cells by Cluster | 1.04e-04 | 190 | 109 | 5 | 8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 190 | 109 | 5 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 190 | 109 | 5 | e2481bd5166fde2cdc0c3824894f2bccb8294fdd | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte|World / Primary Cells by Cluster | 1.04e-04 | 190 | 109 | 5 | 7dbfd543398c63cbe1e68b54bcb5e2291f521935 | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_Tfh|tumor_Lung / Location, Cell class and cell subclass | 1.07e-04 | 191 | 109 | 5 | 3e259eba83f8159d1a1a96b98d0e867fe547c5e7 | |
| ToppCell | (09)_Interm._secr.>cil.-(0)_Reference|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.07e-04 | 191 | 109 | 5 | e63432718d62d39165ba8a66e14bb38c93907ffe | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 191 | 109 | 5 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 191 | 109 | 5 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 191 | 109 | 5 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 192 | 109 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | T/NK_cells-CD56bright_NK_cell|World / Lineage and Cell class | 1.10e-04 | 192 | 109 | 5 | 528b5b790a0e8966d04ffbc83b049c93bac17537 | |
| ToppCell | CV-Healthy-1|CV / Virus stimulation, Condition and Cluster | 1.10e-04 | 192 | 109 | 5 | 934d2e6a65121b24b91d386f7940fb9c1a7357ab | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.10e-04 | 192 | 109 | 5 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 192 | 109 | 5 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-04 | 193 | 109 | 5 | d66cbb8c71bdc57faecb74a16fe3f34cb0b33228 | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 1.12e-04 | 193 | 109 | 5 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.12e-04 | 193 | 109 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.12e-04 | 193 | 109 | 5 | 06ddaeb2fd32895181e23f3f1bb3e9103e79752c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-04 | 193 | 109 | 5 | c1d9c2436503791350086a503d6b98c5c69f44ae | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-04 | 193 | 109 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Mild_COVID-19|World / Disease group,lineage and cell class (2021.01.30) | 1.12e-04 | 193 | 109 | 5 | 325b0768827bf8701bfb7f686bb11fd8b1a41a5c | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.15e-04 | 194 | 109 | 5 | dc4aeee379423827e8d291cffe4dbdf2ff6d0bbe | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.15e-04 | 194 | 109 | 5 | 8c5f716ce05c1f187de63c1b6948eb9f90ff34fe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.15e-04 | 194 | 109 | 5 | 95ab357d5f7bf91ba287417928c8575e655814fc | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-04 | 195 | 109 | 5 | 441345d33f839a9e9222e790752b5603ff572bf2 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_EM_CTLs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.18e-04 | 195 | 109 | 5 | 7df67ad5c62235474ee56ea07a957253d45f066b | |
| ToppCell | T/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class | 1.18e-04 | 195 | 109 | 5 | 6124e87cb9061bf8918377fb4a79084079ddfc16 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.18e-04 | 195 | 109 | 5 | 730c613cf6f4d16ca51fd44de1f5a883f615c5c5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.18e-04 | 195 | 109 | 5 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 103 | 109 | 4 | 3baaf23a9756be41af3a9b4f720e3ab00f1b674d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-04 | 196 | 109 | 5 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CTL|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.21e-04 | 196 | 109 | 5 | ad9b0651cb2a15b750e453b2dcf782bca08b4fe7 | |
| ToppCell | (00)_Basal-(0)_Reference|(00)_Basal / shred by cell type by condition | 1.21e-04 | 196 | 109 | 5 | ba03530a20d7b29902721fd50df8d860557ddefa | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.21e-04 | 196 | 109 | 5 | 21ad9a63242e33038f9f531dd4074a5a9304ed62 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue | 1.21e-04 | 196 | 109 | 5 | e6d4853ccefbcd45a019cee595811f0474dcc036 | |
| ToppCell | Mild|World / Disease group and Cell class | 1.21e-04 | 196 | 109 | 5 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 196 | 109 | 5 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 1.21e-04 | 196 | 109 | 5 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-04 | 196 | 109 | 5 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 196 | 109 | 5 | fa24d7c4b7c65e98b209db302a16c58ceac1a105 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 196 | 109 | 5 | e8db58e82300981f981402618a1befb91f6690fd | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 1.21e-04 | 196 | 109 | 5 | a3b077e82b1550eb328c84b567b60179001f9a77 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 196 | 109 | 5 | 2cf42b702ea15adfa6bbd86a3c9613271863f86c | |
| Computational | Genes in the cancer module 293. | 5.82e-05 | 12 | 71 | 3 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 9.54e-05 | 14 | 71 | 3 | MODULE_143 | |
| Drug | hydroxybutanone | 4.62e-07 | 14 | 108 | 4 | CID000521300 | |
| Drug | Laevuflex | 6.06e-06 | 272 | 108 | 9 | CID000003426 | |
| Drug | rhamnose | 7.67e-06 | 356 | 108 | 10 | CID000000840 | |
| Drug | Ichiba acid | 2.23e-05 | 2 | 108 | 2 | CID000440403 | |
| Drug | 3-HM | 2.23e-05 | 2 | 108 | 2 | CID000439464 | |
| Drug | bromohydroxyacetone phosphate | 2.23e-05 | 2 | 108 | 2 | CID000152675 | |
| Drug | anthracene diol | 2.23e-05 | 2 | 108 | 2 | CID000155464 | |
| Drug | AC1L1I1D | 2.80e-05 | 37 | 108 | 4 | CID000004381 | |
| Drug | 2-keto-4-hydroxyglutarate | 3.64e-05 | 14 | 108 | 3 | CID000000599 | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 3.95e-05 | 194 | 108 | 7 | 4721_DN | |
| Drug | AC1L937T | 5.56e-05 | 16 | 108 | 3 | CID000412305 | |
| Drug | (3S,4S)-pyrrolidine-3,4-diol | 6.67e-05 | 3 | 108 | 2 | CID000146198 | |
| Drug | acetol phosphate | 6.67e-05 | 3 | 108 | 2 | CID000150865 | |
| Drug | (1R,2R,3S,4R)-4-aminocyclopentane-1,2,3-triol | 6.67e-05 | 3 | 108 | 2 | CID010034676 | |
| Drug | Man)6(GlcNAc)2Asn | 6.67e-05 | 3 | 108 | 2 | CID000170160 | |
| Drug | 3,3,3-trifluoropropanoic acid | 6.67e-05 | 3 | 108 | 2 | CID002777972 | |
| Drug | 4-hydroxy-9-fluorenone | 6.67e-05 | 3 | 108 | 2 | CID000016139 | |
| Drug | oligostatin C | 6.67e-05 | 3 | 108 | 2 | CID000174107 | |
| Drug | Htfp | 6.67e-05 | 3 | 108 | 2 | CID000125055 | |
| Drug | Cefadroxil | 6.67e-05 | 3 | 108 | 2 | ctd:D002434 | |
| Drug | DIDIT | 6.67e-05 | 3 | 108 | 2 | CID000196082 | |
| Drug | 2-keto-3-deoxy- l-lyxonate | 6.67e-05 | 3 | 108 | 2 | CID000192781 | |
| Drug | methyl oligobiosaminide | 6.67e-05 | 3 | 108 | 2 | CID003083102 | |
| Drug | 4-fluorothreonine | 6.67e-05 | 3 | 108 | 2 | CID000128057 | |
| Drug | (4S,7R,8R,9R,13Z,16S)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-1-oxacyclohexadec-13-ene-2,6-dione | 6.67e-05 | 3 | 108 | 2 | CID009869661 | |
| Drug | androisoxazole | 6.67e-05 | 3 | 108 | 2 | CID000009676 | |
| Drug | 2-keto-3-bromobutyrate | 6.67e-05 | 3 | 108 | 2 | CID000191968 | |
| Drug | 3-isochromanone | 6.67e-05 | 3 | 108 | 2 | CID000078092 | |
| Drug | 5-deoxy-5-fluoro-L-sorbose | 6.67e-05 | 3 | 108 | 2 | CID000191809 | |
| Drug | D-ribulose-1-p | 6.67e-05 | 3 | 108 | 2 | CID000000615 | |
| Drug | AC1L19ID | 6.67e-05 | 3 | 108 | 2 | CID000000560 | |
| Drug | 4-hydroxy-2-ketopimelate | 6.67e-05 | 3 | 108 | 2 | CID000000553 | |
| Drug | AC1L19F1 | 6.67e-05 | 3 | 108 | 2 | CID000000519 | |
| Drug | C11 -427 | 6.67e-05 | 3 | 108 | 2 | CID000443195 | |
| Drug | AC1Q6DJO | 8.16e-05 | 93 | 108 | 5 | CID000000630 | |
| Drug | I-Hg | 9.52e-05 | 19 | 108 | 3 | CID000447029 | |
| Drug | AC1L2YVP | 9.52e-05 | 19 | 108 | 3 | CID000080135 | |
| Drug | coenzyme 1 | HLA-A HLA-B ADCY5 ADCY6 PARP10 CRYZ EHHADH ALDOA ALDOC DHTKD1 PYCR3 | 1.25e-04 | 596 | 108 | 11 | CID000000925 |
| Drug | acetyltryptophanamide | 1.30e-04 | 21 | 108 | 3 | CID000002003 | |
| Drug | 9-fluorenone-1-carboxylic acid | 1.33e-04 | 4 | 108 | 2 | CID000074083 | |
| Drug | formylacetate | 1.33e-04 | 4 | 108 | 2 | CID000075269 | |
| Drug | benzyl-alpha-D-mannopyranoside | 1.33e-04 | 4 | 108 | 2 | CID000188977 | |
| Drug | dihydroxyacetone sulfate | 1.33e-04 | 4 | 108 | 2 | CID000439751 | |
| Drug | mannonolactam amidrazone | 1.33e-04 | 4 | 108 | 2 | CID000126858 | |
| Drug | AC1L9A8P | 1.33e-04 | 4 | 108 | 2 | CID000440943 | |
| Drug | B-792 | 1.33e-04 | 4 | 108 | 2 | CID003060720 | |
| Drug | C06441 | 1.33e-04 | 4 | 108 | 2 | CID000441020 | |
| Drug | citronellyl alpha-D-mannopyranosyl phosphate | 1.33e-04 | 4 | 108 | 2 | CID000191367 | |
| Drug | Man)5(GlcNAc)2Asn | 1.33e-04 | 4 | 108 | 2 | CID003082495 | |
| Drug | 3-hydroxy-1-indanone | 1.33e-04 | 4 | 108 | 2 | CID000176448 | |
| Drug | l-123 | 1.33e-04 | 4 | 108 | 2 | CID000093552 | |
| Drug | phenanthrene trans-3,4-dihydrodiol | 1.33e-04 | 4 | 108 | 2 | CID000119398 | |
| Drug | DHMP | 1.33e-04 | 4 | 108 | 2 | CID000098784 | |
| Drug | msdC | 1.33e-04 | 4 | 108 | 2 | CID000131526 | |
| Drug | Man5GlcNAc2 | 1.36e-04 | 55 | 108 | 4 | CID003081562 | |
| Drug | AC1LA2MZ | 1.67e-04 | 58 | 108 | 4 | CID000460551 | |
| Drug | Sialic acids | 1.76e-04 | 329 | 108 | 8 | CID000349960 | |
| Drug | vinylidene chloride | FLNA CALCR DOCK8 UNC5B L2HGDH GALNT12 PLEKHB1 MMACHC TFR2 SLC15A2 HP EHHADH GLDC BHMT2 PLCL1 DHTKD1 SLC2A12 SEMA3E | 1.91e-04 | 1475 | 108 | 18 | ctd:C029297 |
| Drug | glycolaldehyde | 2.16e-04 | 62 | 108 | 4 | CID000000756 | |
| Drug | 1,3-dioxan-5-one | 2.21e-04 | 5 | 108 | 2 | CID009793707 | |
| Drug | AC1L4F2K | 2.21e-04 | 5 | 108 | 2 | CID000184526 | |
| Drug | gamma-oxalocitramalate | 2.21e-04 | 5 | 108 | 2 | CID000000130 | |
| Drug | 2,3-dihydroxy-p-cumate | 2.21e-04 | 5 | 108 | 2 | CID000029587 | |
| Drug | f-3p | 2.21e-04 | 5 | 108 | 2 | CID015991581 | |
| Drug | AC1NX490 | 2.21e-04 | 5 | 108 | 2 | CID005743230 | |
| Drug | PMSD | 2.21e-04 | 5 | 108 | 2 | CID000083890 | |
| Drug | alpha-methylserine | 2.21e-04 | 5 | 108 | 2 | CID000094309 | |
| Drug | (2S,3S,4R,5R,6S)-2,6-difluoro-2-(hydroxymethyl)oxane-3,4,5-triol | 2.21e-04 | 5 | 108 | 2 | CID010013013 | |
| Drug | phosphoglycollamide | 2.21e-04 | 5 | 108 | 2 | CID000191768 | |
| Drug | D-erythrulose 1-phosphate | 2.21e-04 | 5 | 108 | 2 | CID000152153 | |
| Drug | didecyl sulfate | 2.21e-04 | 5 | 108 | 2 | CID011760650 | |
| Drug | alpha-ManMNT | 2.21e-04 | 5 | 108 | 2 | CID006438897 | |
| Drug | brinzolamide | 2.21e-04 | 5 | 108 | 2 | ctd:C111827 | |
| Drug | hydroxypyruvaldehyde phosphate | 2.21e-04 | 5 | 108 | 2 | CID000193787 | |
| Drug | indolizidine | 2.21e-04 | 25 | 108 | 3 | CID000026136 | |
| Drug | 1,2-dideoxy-d-arabino-hex-1-enopyranose | 2.21e-04 | 25 | 108 | 3 | CID000089465 | |
| Drug | AC1L2T2K | 2.49e-04 | 26 | 108 | 3 | CID000128038 | |
| Drug | tetrahydrofurfuryl alcohol | 3.12e-04 | 28 | 108 | 3 | CID000007360 | |
| Drug | AC1L4P7I | 3.12e-04 | 28 | 108 | 3 | CID000189746 | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.21e-04 | 193 | 108 | 6 | 4466_UP | |
| Drug | mycestericin D | 3.30e-04 | 6 | 108 | 2 | CID006439504 | |
| Drug | 1-deoxycastanospermine | 3.30e-04 | 6 | 108 | 2 | CID000195154 | |
| Drug | 5-amino-5-deoxy-D-mannopyranose | 3.30e-04 | 6 | 108 | 2 | CID000124624 | |
| Drug | propyltrimethoxysilane | 3.30e-04 | 6 | 108 | 2 | CID000061254 | |
| Drug | AC1L18Q4 | 3.30e-04 | 6 | 108 | 2 | CID000000210 | |
| Drug | C02783 | 3.30e-04 | 6 | 108 | 2 | CID000439805 | |
| Drug | 2,2-dimethyl-1,3-dioxan-5-one | 3.30e-04 | 6 | 108 | 2 | CID002733141 | |
| Drug | 2-(N-decyl)aminonaphthalene-6-sulfonic acid | 3.30e-04 | 6 | 108 | 2 | CID000189836 | |
| Drug | parapyruvate | 3.30e-04 | 6 | 108 | 2 | CID000440249 | |
| Drug | 7-oxoheptanoic acid | 3.30e-04 | 6 | 108 | 2 | CID000169732 | |
| Drug | alizarin 1-methyl ether | 3.30e-04 | 6 | 108 | 2 | ctd:C035010 | |
| Drug | acetyldithio-CoA | 3.30e-04 | 6 | 108 | 2 | CID003082679 | |
| Drug | 0 Gz | 3.30e-04 | 6 | 108 | 2 | CID000000372 | |
| Drug | chloroacetol phosphate | 3.30e-04 | 6 | 108 | 2 | CID000168137 | |
| Drug | cyclic oxamide | 3.30e-04 | 6 | 108 | 2 | CID000468476 | |
| Drug | rubiadin | 3.30e-04 | 6 | 108 | 2 | ctd:C072500 | |
| Drug | benzyloxyacetaldehyde | 3.30e-04 | 6 | 108 | 2 | CID000108989 | |
| Drug | AC1L970Z | 3.47e-04 | 29 | 108 | 3 | CID000439275 | |
| Drug | 1-o-phosphonohex-2-ulose | 3.47e-04 | 29 | 108 | 3 | CID000000481 | |
| Drug | enamines | 3.47e-04 | 29 | 108 | 3 | CID000011642 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.61e-06 | 7 | 107 | 3 | DOID:0081267 (implicated_via_orthology) | |
| Disease | – | 1.30e-05 | 2 | 107 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 1.30e-05 | 2 | 107 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 1.30e-05 | 2 | 107 | 2 | cv:CN077964 | |
| Disease | eosinophil count | DIP2B FLNA ATR HLA-A HLA-B HLA-G PRSS33 ERN2 TFR2 PPP1CC LIMK2 ZDHHC12 TNFSF11 MDN1 GLDC ALDOA KPNA2 | 2.51e-05 | 1488 | 107 | 17 | EFO_0004842 |
| Disease | polycystic ovary syndrome, fasting blood glucose measurement | 3.90e-05 | 3 | 107 | 2 | EFO_0000660, EFO_0004465 | |
| Disease | Post-Traumatic Osteoporosis | 7.27e-05 | 61 | 107 | 4 | C0751406 | |
| Disease | Osteoporosis, Senile | 7.27e-05 | 61 | 107 | 4 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 7.27e-05 | 61 | 107 | 4 | C0001787 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 7.78e-05 | 4 | 107 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | Osteoporosis | 8.26e-05 | 63 | 107 | 4 | C0029456 | |
| Disease | obesity (implicated_via_orthology) | 1.37e-04 | 215 | 107 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Disproportionate short stature | 1.80e-04 | 77 | 107 | 4 | C0878659 | |
| Disease | anxiety, vitamin D measurement | 2.70e-04 | 7 | 107 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | mitral valve prolapse (is_implicated_in) | 4.61e-04 | 9 | 107 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Anemia, Sickle Cell | 5.75e-04 | 10 | 107 | 2 | C0002895 | |
| Disease | myeloid white cell count | BICD2 SELP DNAJC13 AHI1 HLA-A HLA-B DOCK8 HNF4A ADCY5 PKD1 ACOXL | 6.04e-04 | 937 | 107 | 11 | EFO_0007988 |
| Disease | platelet crit | BICD2 DIP2B AHI1 HLA-A HLA-B ADCY5 TFR2 SLC15A2 EXOC3L4 ALDOA TNPO3 | 6.88e-04 | 952 | 107 | 11 | EFO_0007985 |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0801494 | |
| Disease | beta-2 microglobulin measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0005197 | |
| Disease | age at menopause | 8.32e-04 | 302 | 107 | 6 | EFO_0004704 | |
| Disease | Cooley's anemia | 8.40e-04 | 12 | 107 | 2 | C0002875 | |
| Disease | dermatomyositis | 8.40e-04 | 12 | 107 | 2 | EFO_0000398 | |
| Disease | Thalassemia Intermedia | 8.40e-04 | 12 | 107 | 2 | C0271979 | |
| Disease | Thalassemia Minor | 8.40e-04 | 12 | 107 | 2 | C0085578 | |
| Disease | Hereditary hemochromatosis | 8.40e-04 | 12 | 107 | 2 | C0392514 | |
| Disease | Hemochromatosis | 8.40e-04 | 12 | 107 | 2 | C0018995 | |
| Disease | beta Thalassemia | 8.40e-04 | 12 | 107 | 2 | C0005283 | |
| Disease | Hypercalcemia | 9.90e-04 | 13 | 107 | 2 | C0020437 | |
| Disease | Milk-Alkali Syndrome | 9.90e-04 | 13 | 107 | 2 | C0026141 | |
| Disease | apolipoprotein A 1 measurement | HLA-B HLA-G HMBS PUM2 HNF4A ADCY5 PPARGC1B ATG4C ACOXL MYBPC3 | 1.04e-03 | 848 | 107 | 10 | EFO_0004614 |
| Disease | Eczema, allergic rhinitis | 1.14e-03 | 215 | 107 | 5 | EFO_0005854, HP_0000964 | |
| Disease | Kawasaki disease (is_marker_for) | 1.15e-03 | 14 | 107 | 2 | DOID:13378 (is_marker_for) | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.17e-03 | 126 | 107 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.17e-03 | 713 | 107 | 9 | EFO_0005689 | |
| Disease | Hemoglobin F Disease | 1.33e-03 | 15 | 107 | 2 | C0019025 | |
| Disease | cytokine measurement | 1.48e-03 | 461 | 107 | 7 | EFO_0004873 | |
| Disease | neutrophil count | BICD2 SELP MPZ DNAJC13 AHI1 HLA-A HLA-B DOCK8 HLA-G HNF4A PKD1 PLCL1 ACOXL | 1.49e-03 | 1382 | 107 | 13 | EFO_0004833 |
| Disease | Allergic Reaction | 1.57e-03 | 63 | 107 | 3 | C1527304 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.59e-03 | 137 | 107 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | Hypersensitivity | 1.64e-03 | 64 | 107 | 3 | C0020517 | |
| Disease | Glycogen storage disease | 1.71e-03 | 17 | 107 | 2 | cv:C0017919 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.88e-03 | 67 | 107 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.90e-03 | 144 | 107 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | nevus count | 1.92e-03 | 18 | 107 | 2 | EFO_0004632 | |
| Disease | response to methotrexate, neurotoxicity | 2.14e-03 | 19 | 107 | 2 | EFO_0011057, GO_0031427 | |
| Disease | maximal midexpiratory flow rate | 2.37e-03 | 20 | 107 | 2 | EFO_0004313 | |
| Disease | atherosclerosis (biomarker_via_orthology) | 2.37e-03 | 20 | 107 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | seborrheic dermatitis | 2.37e-03 | 20 | 107 | 2 | EFO_1000764 | |
| Disease | erythrocyte measurement | 2.49e-03 | 257 | 107 | 5 | EFO_0005047 | |
| Disease | mean reticulocyte volume | 2.53e-03 | 799 | 107 | 9 | EFO_0010701 | |
| Disease | autism spectrum disorder | 2.54e-03 | 156 | 107 | 4 | EFO_0003756 | |
| Disease | haptoglobin measurement | 2.62e-03 | 21 | 107 | 2 | EFO_0004640 | |
| Disease | fat intake measurement | 2.87e-03 | 22 | 107 | 2 | EFO_0010809 | |
| Disease | apolipoprotein B measurement | 2.89e-03 | 663 | 107 | 8 | EFO_0004615 | |
| Disease | monocyte count | SELP MPZ AHI1 HLA-A HLA-B SZT2 DOCK8 ADCY5 PKD1 ALDOA ACOXL MYBPC3 | 3.02e-03 | 1320 | 107 | 12 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PHLGAYINACEELRT | 476 | Q17RC7 | |
| NGCEYFVLAPHRVAL | 426 | Q6UXG8 | |
| EVDINGPEILACKYH | 426 | Q8TD16 | |
| HPAVRELVVTGCYDS | 706 | Q8N157 | |
| GDIPIYICHQEPRNE | 436 | P30988 | |
| ILPDGDHDLKRCQYV | 191 | P09972 | |
| VIGICTHYPAEVSQR | 301 | O43306 | |
| ILPDGDHDLKRCQYV | 191 | P04075 | |
| YCPAHEVGLVSLQVA | 586 | O94983 | |
| RIPFILASQEGHYDC | 881 | Q9ULJ7 | |
| RVRAEYCEHGPALEQ | 201 | Q8WXF8 | |
| IVGVCTHYPAEVSQR | 391 | O95622 | |
| PVDHGLARLVTVYCE | 51 | Q96HY7 | |
| EEARHPDLQGITIYV | 246 | Q96DT6 | |
| IAPGVIYDVHHQCQL | 466 | P58397 | |
| VYCLERQAGPVDEEH | 846 | Q9UKP4 | |
| HCFIVPVRDENGSLY | 156 | Q9NUZ1 | |
| DPGLCEVVRVHEHYL | 96 | O95825 | |
| KVHACGVNPVETYIR | 41 | Q08257 | |
| IRYICGVVHPSNEVL | 351 | Q68E01 | |
| STHPYGCRVIQRILE | 881 | Q8TB72 | |
| TCVYIAEIAPQHRRG | 151 | Q8TD20 | |
| VVVPSGEEQRYTCHV | 271 | P01893 | |
| VVVPSGEEQRYTCHV | 271 | P17693 | |
| ILAARLPDSGVYVCH | 196 | O75147 | |
| RFHIIPDGNCLYRAV | 311 | Q5VV17 | |
| DLPHYVALCFGEVRI | 81 | Q14667 | |
| LNACFDHRGEIYVPE | 1836 | Q9NU22 | |
| VRESARHPGDYVLCV | 146 | P42679 | |
| ASGGPHIVCILDVYE | 91 | Q16644 | |
| LPVADQDQCIRHYEG | 301 | P00738 | |
| DCPHTGIVDYRQVAL | 186 | Q9H9P8 | |
| DEIEYDVPCHLQGRL | 426 | Q9UBI9 | |
| YSQQIFRPCDLIHGE | 321 | P53671 | |
| ERGPQFHYIALELCR | 581 | Q76MJ5 | |
| QPIHECREVILGYDY | 451 | Q5HYC2 | |
| YELERPKSVIICQHG | 951 | Q2LD37 | |
| IVPEEHLQQCRVYRG | 176 | Q96KR4 | |
| SVEILPCSRVGHIYQ | 406 | Q8N3T1 | |
| YRIAHAEAQVGLPEV | 111 | Q08426 | |
| DVLLLGNDYIVPRHC | 241 | P41235 | |
| AICRPLHYEVIINQG | 126 | Q8NHC6 | |
| TQRAAECVHRGFPEI | 131 | P14543 | |
| VELGLNDYLDIVCPH | 46 | P52798 | |
| DVVRVVGAYNQCPVV | 366 | Q8N2G8 | |
| ETCVHYVGGPLDALI | 631 | Q9H6R4 | |
| DSIHQVGVYCLALVP | 886 | Q9P265 | |
| HGYVLISKEVEDCVP | 571 | Q96RT7 | |
| RTCDGLYHVGADVPQ | 191 | Q8NF86 | |
| LYHVGADVPQAERIV | 196 | Q8NF86 | |
| ILCYGHVAARAPREL | 741 | Q8NDA8 | |
| VVVPSGEEQRYTCHV | 271 | P01889 | |
| INYSAIHPGLCEDLR | 616 | P16144 | |
| TDPVDQCVAYHLGRV | 76 | Q9Y4U1 | |
| VVCRSLGYPGVQAVH | 386 | P21757 | |
| STHPYGCRVIQRILE | 1001 | Q14671 | |
| EQIVYLVHCGIIEPL | 411 | P52292 | |
| LDLICRAHQVVEDGY | 241 | P62136 | |
| CPAHVVFRYQAGRED | 471 | Q86WN1 | |
| PHLYSCLEDRNGDVR | 1021 | Q14008 | |
| HIRTYAVIPLNDECG | 2361 | Q13535 | |
| VRISDNGPYECHVGI | 106 | Q96ID5 | |
| DIPYQEIAGEHLRIC | 46 | Q9Y625 | |
| EIAGEHLRICPQEYT | 51 | Q9Y625 | |
| CGFEPYHIRAIAEEL | 291 | Q9H2M3 | |
| GVELDPHVRDCVQTY | 111 | Q8NF50 | |
| VEGENHTYCIRFVPA | 2191 | P21333 | |
| DIPHCNVVVRYGLLT | 446 | Q96C10 | |
| IRYNTHQPEGCIAVE | 496 | Q8IXK2 | |
| ALAIVYGRCHEEIGP | 876 | O75165 | |
| VVVPSGEEQRYTCHV | 271 | P04439 | |
| YVRECGELELPQHVL | 196 | P16109 | |
| LCHRIEQEYQAGPLE | 696 | Q9Y2E5 | |
| EVVLDVGCPYVRFHT | 786 | Q9NTJ4 | |
| NQIHTLCERPTYGEV | 11 | Q12912 | |
| RVGQILHPEECMYAV | 201 | P08397 | |
| VQRGEYPAVHCRTED | 551 | Q16348 | |
| VCGVTHDPRVTIRYI | 516 | Q58EX2 | |
| YLEQGECVPDTHVER | 46 | Q96RY7 | |
| VVVTVLPRYHGNDCL | 1281 | Q8TDX9 | |
| FVHYPRQQECGIAVL | 151 | Q9BQ95 | |
| EIFPGNGHCYRLVVE | 411 | P98161 | |
| CERRPVEQVLYHGTT | 876 | Q53GL7 | |
| YEPGAAELRVHVIQC | 276 | Q8IYJ3 | |
| GYDILHDVSCALRQP | 466 | Q5T011 | |
| APEVADRIGDYVQCH | 261 | P49590 | |
| EVIECGNYCGVRIIH | 971 | Q5K651 | |
| VRIVPRGHTACADAY | 226 | O14841 | |
| DHDYCQVLRPEGVLQ | 691 | Q86YN6 | |
| EEVFICYGPHDNQRL | 266 | Q9NVD3 | |
| YECRLPAGAIHFQRE | 71 | Q13438 | |
| RCEEVPEAYVDIHTG | 161 | Q53H96 | |
| VVEGERGNRPHIYCL | 2191 | O15417 | |
| AKGDVIDPYVCIEIH | 741 | Q15111 | |
| LRFGAINCREYEPDH | 236 | Q6P1L6 | |
| GAAVVYPCHAVIVVL | 381 | Q96KV7 | |
| YPCHAVIVVLLVDTG | 386 | Q96KV7 | |
| PAEHLRQIGGEAYLC | 246 | Q5T0L3 | |
| GVTHVIVREDPCYSA | 201 | Q9UF11 | |
| VVIEHCTSURVYGRN | 36 | Q8IZQ5 | |
| HEVPVYGSRCVDITG | 286 | A0A1W2PR48 | |
| EPRACHILLDQLGTY | 666 | Q8IZJ1 | |
| LDLICRAHQVVEDGY | 241 | P36873 | |
| CYADVVVLRHPQPGA | 2016 | P27708 | |
| PNRISEDGTHCIYRI | 76 | O14788 | |
| LLLICAGHPQYEVVE | 326 | Q9Y5L0 | |
| VCAFIRVGYHLEDPL | 141 | O15041 | |
| ENCVGERNHPLFVVY | 131 | Q96GR4 | |
| GYEIACRKAHEILPN | 131 | P50990 | |
| CIEGRSEPDHYVVIG | 416 | Q9UP52 | |
| HYCEGLRPDISLVDQ | 451 | Q9NX78 | |
| VGIQTRDVYCLHPGE | 721 | P82987 | |
| IARIDDIYGDQHLVC | 986 | P23378 | |
| YIVVDPILRVGADNH | 106 | P35573 | |
| PAQAIVVYTDREVHG | 26 | P25189 | |
| RTHCVVPELIIGNGY | 1121 | Q14896 |